江苏华兰药用新材料股份有限公司

Recently, the company received the invitation letter on “2016 First China Drugs Surveillance Science Conference” to be held on September 20-21, 2016 by China Society for Drug Regulation, specially inviting chairman Hua Guoping as the only representative of drug package material industry to participate in this meeting sub-forum two (latest pharmaceutic adjuvant and drug package material policy and regulation interpretation and technological innovation application) speech. The speech subject is influence of high barrier seal elastomer to injection’s security. This meeting invites the China Food and Drug Administration and its directly controlled organs leaders and domestic and foreign pharmaceutical science and technology and industry academicians, experts, scholars and entrepreneurs to conduct authority and academic interpretation and thorough analysis and research around current a series of pharmaceutical supervisory and administrative reform measures and difficulties faced with medical innovation and development, providing communication and cooperation platform for the whole industry.

Chairman Hua hopes that through this meeting, Hualan NPM can communicate with experts and leaders on stage to allow everyone to understand the research and development tendency of Hualan Company in new product on the one hand and on the other hand improve the academic status of Hualan NPM in the industry through the meeting, improving brand value for Hualan NPM.